Cascadia Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$715K Sell
5,706
-34
-0.6% -$4.4K 0.15% 149
2021
Q2
$713K Sell
5,740
-311
-5% -$39K 0.15% 142
2021
Q1
$715K Buy
+6,051
New +$709K 0.16% 139
2020
Q3
$862K Sell
8,291
-13,945
-63% -$1.4M 0.24% 119
2020
Q2
$2.04M Buy
+22,236
New +$2.13M 0.62% 51
2019
Q4
$2.26M Buy
+19,926
New +$2.19M 0.64% 38

Other funds holding MDT

Cascadia Advisory Services's MDT Position: Q3 2021 in Review

Cascadia Advisory Services reduced its Medtronic (MDT) stake by 0.59% in Q3 2021, selling an estimated $4.4K and leaving 5,706 shares worth $715K. The position accounts for 0.15% of the portfolio, ranked #149.

Cascadia Advisory Services first reported a position in MDT in Q4 2019 and has held it in 6 quarters since. The position peaked at $2.26M in Q4 2019. 2,024 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Cascadia Advisory Services held 5,706 shares of Medtronic worth $715K as of Q3 2021.
  • Cascadia Advisory Services sold 34 Medtronic shares in Q3 2021, an estimated $4.4K.
  • Medtronic made up 0.15% of Cascadia Advisory Services's portfolio in Q3 2021, its #149 holding.
  • Cascadia Advisory Services first reported a position in Medtronic in Q4 2019 and has held it in 6 quarters since.
  • Cascadia Advisory Services's Medtronic position peaked at $2.26M in Q4 2019.
  • 2,024 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Cascadia Advisory Services's 13F filing for Q3 2021, filed 12 Nov 2021.